New Study Shows Novartis Drug Helps Delay Breast Cancer Recurrence

Recent clinical trials of a drug developed by Novartis have revealed promising results in the fight against breast cancer. The effectiveness of this new drug in preventing disease recurrence has been confirmed through major studies conducted across multiple countries. Participants in the trials who were on this drug showed a significant delay in the return of the disease compared to those using standard treatment methods.

Continue reading